Document

We consent to the incorporation by reference in this Registration Statement to Form S-3 of our audit report dated November 26, 2024, with respect to the consolidated balance sheets of Decoy Therapeutics, Inc. as of December 31, 2023 and 2022, and the related consolidated statements of operations, shareholders’ equity, and cash flows for each of the years in the two-year period ended December 31, 2023. Our report relating to those financial statements includes an emphasis of matter paragraph regarding substantial doubt as to the Company’s ability to continue as a going concern.